Please cite this article as: Hamel R, De La Fontaine É, Bernier P-M, Lepage J-F, Letter to the editor: No influence of static magnetic stimulation applied for 30 minutes over the human M1 on corticospinal excitability, Brain Stimulation, https://doi.A total of 18 participants (7 females; 21.7 ± 1.2 years old; mean ± SEM) were 89 recruited to ensure a 98.7% chance (achieved power analysis conducted with G*Power 90 v3.1.9.2) of replicating the effect size reported by Dileone et al., 2018 1 (two-tailed t-tests; 91 Cohen's dz = 1.070; comparison immediately following tSMS removal). Participants 92 were neurologically healthy and were screened for TMS contraindications prior to the 93 experiment. Procedures were approved by the local ethics committee and participants 94 gave their informed written consent. 95 Electromyographic (EMG) data were recorded in a tendon-belly arrangement 96 from the right FDI. The ground electrode was placed on the lateral epicondyle of the right 97 humerus, and the reference electrode on the distal portion of the right index. The EMG 98 signal was amplified using a Powerlab 4/20 system (ADinstruments, Colorado Springs, 99 CO), filtered with a 0.3-1000Hz bandpass and digitized at a sampling rate of 4 kHz. 100 tSMS was applied for 30 minutes over the FDI hotspot in the left M1. tSMS was 101 tightly held in place against the scalp using a custom-made set of nonskid straps 102 comfortably attached around participants' head. 103 Single pulses of TMS were delivered using a Magstim BiStim 2 (The Magstim 104 Company, Whitland, UK) with a 70mm figure-of-eight coil. The resting motor threshold 105
Dear editor: 26 We have read with great interest the article recently published by Dileone et al. 27 (2018) 1 reporting that a 30-min application of transcranial static magnetic stimulation 28 (tSMS) over the human primary motor cortex (M1) can yield long-lasting (~30 min) 29 inhibition of corticospinal excitability (CSE), an effect that is reminiscent of long-term 30 depression plasticity. These results are exciting as they open the door for potential 31 therapeutic applications of tSMS, especially since the technique is portable, inexpensive, 32 and requires little training for its utilization. Due to the potential implications of these 33 results, and because they were obtained in small (n ≤ 10) and non-independent samples, it 34 appears important to ascertain the effectiveness of tSMS to induce lasting changes in 35 CSE and, hopefully, to avoid the pitfalls and controversies encountered with other non-36 invasive brain stimulation techniques (NIBS) in the past 2 .
37
Here, tSMS (nickel-plated neodymium disc magnet; 50 mm diameter, 50 mm 38 thickness, axially magnetized, 139Kg pull force) was applied over M1 for 30 min (n = 39 18) and CSE was assessed immediately after and up to 58 min after tSMS removal by 
Results

51
To determine if tSMS altered normalized MEP amplitude, each post-measurement 52 was separately compared to the value of 1 (100%) using two-tailed one-sample t-tests.
53
The results revealed no effect of tSMS on MEP amplitude at any of the 6 post- 
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